Understanding Clinical Trials - ClinicalTrials.gov

Ben Hirschler Health Communicator

Also Shared By:

Michael Fisch

UMass Memorial

Actelion breathes easy on best case new drug data | Reuters

reuters.com — “ZURICH/LONDON (Reuters) - A new lung and heart drug from Actelion beat expectations in a key clinical trial, giving a much-needed boost to its pipeline and providing Europe's leading biotech company with” View full resource at reuters.com

Most Recently Shared on April 30, 2012 at 8:44 am By:

#Actelion breathes easy on "best case" new drug data - stock up 18% http://t.co/Y0kr5VdG via @reuters

5 days ago...

Lungs and Breathing OW Health

Actelion Lung Drug Meets Main Goal in Pivotal Study - Bloomberg

bloomberg.com — “Actelion Ltd.’s experimental lung drug macitentan met the main goal of a late-stage clinical trial, giving the company a possible successor to a treatment that accounts for 89 percent of sales. The shares rose the most since the company went public in 2000.” View full resource at bloomberg.com

Most Recently Shared on April 30, 2012 at 6:12 am By:

Actelion Lung Drug Meets Main Goal in Pivotal Patient Study: Actelion Ltd. (ATLN) ’s experimental lung drug maci... http://t.co/YcbqEfeX

5 days ago...

How the FDA Stifles New Cures, Part I: The Rising Cost of Clinical Trials - Forbes

forbes.com — “Today, the Manhattan Institute released a study I authored, entitled “Stifling New Cures: The True Cost of Lengthy Clinical Drug Trials.” (You can read the full report here.) The paper discusses how outdated FDA policies are making drug development too expensive and too risky. In this excerpt, I describe the factors that are driving up the cost of clinical trials.” View full resource at forbes.com

Most Recently Shared on April 25, 2012 at 12:02 am By:

Matthew Bowdish MD Doctor, Internist, Allergist, and Physician

How the FDA Stifles New Cures, Part I: The Rising Cost of Clinical Trials by @aviksaroy http://t.co/EfMDpHmv

1 week ago...

Doctor’s Toolbag app is an excellent evidence based clinical decision support tool

imedicalapps.com — “Doctor’s Toolbag app is an excellent app to help understand, calculate and manage patients with specific conditions” View full resource at imedicalapps.com

Most Recently Shared on April 24, 2012 at 2:55 pm By:

iMedicalApps.com

Doctor's Toolbag app is an excellent evidence based clinical decision support tool http://t.co/4PEMQEkH

Corengi is changing the way patients discover clinical trials

imedicalapps.com — “Corengi, the AdSense of clinical trials, is using embeddable widgets on third-party website to help patients find and better understand clinical trials.” View full resource at imedicalapps.com

Most Recently Shared on April 24, 2012 at 1:29 pm By:

iMedicalApps.com

Corengi is changing the way patients discover clinical trials http://t.co/3norWqHX

Simpler Language, More Access to Results Sought for Clinical-Trial Volunteers - Health Blog - WSJ

blogs.wsj.com — “Pressure is growing on researchers to do a better job of communicating the results of clinical trials to the volunteers who participated.” View full resource at blogs.wsj.com

Most Recently Shared on April 24, 2012 at 12:52 pm By:

Alzheimer's Reading Room is the number one source of life news for the entire Alzheimer's community. Our goal is to Educate, sometimes Entertain, and Empower Alzheimers caregivers and their families worldwide.

" /> Alzheimer's Reading Room Health Advocate

Simpler Language, More Access to Results Sought for Clinical-Trial Volunteers: Pressure is gr... http://t.co/fBynlPEN @AlzheimersRead

Services Match Patients With Clinical Trials - WSJ.com

online.wsj.com — “A growing number of patient-advocacy groups are playing matchmaker, linking patients to clinical trials.” View full resource at online.wsj.com

Most Recently Shared on April 24, 2012 at 10:21 am By:

Seth Bilazarian Cardiologist, Physician, Active Health Library, Doctor, and Internist

@WSJ Matching Patients With Clinical Trials http://t.co/xRSlBm2l > pts want easier access to info, advocacy groups deliver

Dr Michael Banks - The Doctor's Channel Health Site

Naproxen lessens pegfilgrastim-induced bone pain - The Doctor's Channel

thedoctorschannel.com — “NEW YORK (Reuters Health) – Cancer patients given pegfilgrastim experience less bone pain if they take naproxen 500 mg twice daily for about a week, according to the results of a randomized placebo-controlled trial reported in the Journal of Clinical Oncology online April...” View full resource at thedoctorschannel.com

Most Recently Shared on April 23, 2012 at 10:21 pm By:

How have your patients responded to the use of naproxen? - From Reuters Health/TDC http://t.co/0TVzztOX #cancer #pain #health

NextBio Announces NextBio Clinical, Integrates Patient Genomic Data | Biomarker Commons

biomarkercommons.org — “NextBio announced today NextBio Clinical, an extension of the company’s existing life sciences platform to translational medicine applications such as biomarker discovery and clinical trial optimization. NextBio Clinical enables the application of clinical information earlier in the discovery process to enhance research and development.” View full resource at biomarkercommons.org

Most Recently Shared on April 23, 2012 at 2:43 pm By:

Walter Jessen, PhD Pharma, Research, PhD, Active Health Library, and Doctor

Clinical reasoning should trump memorization — db's Medical Rants

medrants.com — “Readers know that I have serious problems with how we test students finishing the first two years of medical school. The test drives our curriculum. Thus, too often we teach facts and details rather than understanding. We do not prioritize” View full resource at medrants.com

Most Recently Shared on April 23, 2012 at 10:11 am By:

Robert Centor Internist, Physician, and Doctor

Medrants: Clinical reasoning should trump memorization http://t.co/KLKSxNsG

Study: Use of drug following first sign of possible MS reduces likelihood of progression to MS

eurekalert.org — “People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21-28, 2012.” View full resource at eurekalert.org

Most Recently Shared on April 20, 2012 at 7:17 am By:

Neurology OW OW Health

Study: Use of drug following first sign of possible MS reduces likelihood of progression to MS: ( American Acade... http://t.co/DJO0pAcf

Revised View Enhances Provenge OS Data

onclive.com — “A further analysis of clinical trial data for sipuleucel-T suggests that it may have delivered a greater OS benefit than previously described.” View full resource at onclive.com

Most Recently Shared on April 19, 2012 at 9:28 pm By:

Editor Oncology

Revised View Enhances Provenge OS Data http://t.co/0tCNQgLP #prostatecancer

What is a Media Psychologist? — Dr. Pamela Rutledge

pamelarutledge.com — “I get lots of questions about media psychology, such as ‘What is media psychology?’ and ‘What does a media psychologist do?’ A big stumbling block is the common understanding of a media psychologist as a psychologist who appears in the media. That's the wrong answer.” View full resource at pamelarutledge.com

Most Recently Shared on April 19, 2012 at 5:44 pm By:

Dr. Pamela Rutledge Psychologist, Health Social Media, PhD, and Doctor

New blog post: Media Psychologist, Clinical Psychologist or Media Personality? http://t.co/o8Y9nGkS

Scott Strumello Patient Expert

Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's... -- PARIS, April 19, 2012 /PRNewswire/ --

prnewswire.com — “Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's Disease. - Fox Foundation to sponsor a clinical trial to study Sanofi compound -.” View full resource at prnewswire.com

Most Recently Shared on April 19, 2012 at 1:15 pm By:

PR: Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's http://t.co/VR1kr3k3 via @PRNewswire